David P. Bonita, Director at Repare Therapeutics Inc. (RPTX), sold 74,614 shares at $33.94 ($2.5M) on 2021-08-31, disclosed to the SEC on 2021-09-02.
Open-market sale of $2.5M RPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.94 | 249 | $8K | 0.3% |
| 2 | $33.94 | 8,223 | $279K | 11.0% |
| 3 | $33.94 | 8,223 | $279K | 11.0% |
| 4 | $33.98 | 382 | $13K | 0.5% |
| 5 | $33.98 | 12,586 | $428K | 16.8% |
| 6 | $33.98 | 12,586 |
| $428K |
| 16.8% |
| 7 | $34.24 | 483 | $17K | 0.7% |
| 8 | $34.24 | 15,941 | $546K | 21.5% |
| 9 | $34.24 | 15,941 | $546K | 21.5% |
| Total | $34.08 avg | 74,614 | $2.5M | 100% |
| Filing → |
| PRLD | BUY | 2023-05-24 | $10.0M | — | Filing → |
| TCDA | SELL | 2022-11-25 | $3.2M | — | Filing → |
| THRD | BUY | 2022-09-21 | $5.1M | — | Filing → |